SuanNutra, a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF

Rhea-AI Summary

SuanNutra, a Carbyne Equity Partners portfolio company, has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The acquired operations will be merged with SuanNutra to form an enlarged global group focused on science-backed natural ingredients.

The combined business will offer clinically supported branded ingredients, botanical extraction at source, fermented vitamins and minerals, and plant-derived natural colours, antioxidants and flavours. The group will have around 700 employees, serving more than 1,200 customers in over 60 countries, with manufacturing across Spain, Slovenia, Peru and the United States. Completion is targeted by the end of 2026, subject to regulatory clearances and customary conditions.

Positive

• Acquisition of IFF specialty ingredients businesses to expand SuanNutra’s natural ingredients portfolio
• Around 700 employees in the combined group across multiple regions
• More than 1,200 customers served in over 60 countries after the merger
• Global manufacturing footprint spanning Spain, Slovenia, Peru and the United States
• Expanded clinically supported branded ingredients, fermented vitamins/minerals and plant-derived colours and antioxidants

Negative

• Deal completion by end of 2026 is subject to regulatory clearances and customary closing conditions

News Market Reaction – IFF

-1.19%

-1.19% Session close to close

In the Jul 20 session, IFF declined 1.19%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

IFF Form 4 filings recorded Net Buying, including 273,500 shares purchased by director Paul J. Fribo...

Analysis

IFF Form 4 filings recorded Net Buying, including 273,500 shares purchased by director Paul J. Fribourg. That record provides ownership context for the acquisition announcement; regulatory clearances remain the stated risk to completion.

Key Figures

Expected completion: End of 2026 Employees: Around 700 employees Customers: More than 1,200 customers +1 more

4 metrics

Expected completion End of 2026 Subject to regulatory clearances and customary closing conditions

Employees Around 700 employees Combined group

Customers More than 1,200 customers Combined group

Countries served Over 60 countries Combined group

Historical Context

5 past events · Latest: Jul 09 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 09	Earnings date notice	Neutral	-1.3%	Announcement of second-quarter results release date and investor webcast schedule
Jun 30	Technology launch	Positive	+3.6%	Launch of SENSORA pro-fragrance platform for controlled scent release
Jun 16	Education program milestone	Neutral	-0.7%	Ten-year collaboration milestone for joint scent design education program
Jun 09	Sustainability report	Positive	+2.7%	Publication of sustainability report highlighting nature-based innovation progress
May 29	Business divestiture	Negative	-2.5%	Agreement to sell Food Ingredients business to CVC for $4.3 billion

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

IFF's recent news reactions were mixed, including a negative response to its Food Ingredients divestiture and positive responses to selected innovation and sustainability announcements.

Key Terms

nutraceuticals, botanical extraction, antioxidants, clean-label

4 terms

nutraceuticals medical

"natural portfolio across nutraceuticals and food enhancement"

Nutraceuticals are products made from food sources that claim to provide extra health benefits beyond basic nutrition, such as dietary supplements, fortified foods, and concentrated extracts—think vitamin pills or functional foods marketed for specific wellness effects. They matter to investors because demand, regulatory rules, and scientific evidence strongly influence sales, pricing and risk: solid clinical support and clear regulations can boost a product’s market value, while weak evidence or regulatory action can cut revenues quickly.

botanical extraction technical

"owned botanical extraction at source"

The process of separating and concentrating specific chemical compounds from plants using solvents, heat, pressure, or mechanical methods so those compounds can be used in medicines, supplements, foods, or cosmetics. It matters to investors because extraction method and efficiency determine product purity, regulatory compliance, yield and production cost—similar to how different ways of squeezing fruit change how much juice you get and how clean it is for sale.

antioxidants medical

"plant-derived natural colours, antioxidants and flavours"

Antioxidants are substances—molecules found in foods, supplements, and medicines—that slow or stop chemical processes that can damage cells, similar to how a rust inhibitor or a small fire extinguisher prevents wear and tear. Investors care because antioxidant claims and evidence can drive consumer demand, affect product labeling and regulatory scrutiny, influence clinical trial outcomes, and therefore shape sales, reputations, and the valuation of companies in food, wellness and pharmaceutical markets.

clean-label technical

"natural and clean-label ingredients"

Clean-label describes food, beverage, supplement, or cosmetic products that use short, familiar ingredient lists and avoid artificial colors, flavors, preservatives, or hard-to-recognize chemicals; the label reads like a simple grocery list. Investors care because it signals a consumer-driven premium and growth opportunity, influences reformulation costs and supply chains, and can reduce regulatory and reputational risk—similar to a product dressing itself in plain, trustworthy clothing to attract buyers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MADRID, July 20, 2026 /PRNewswire/ -- SuanNutra, a global provider of science-backed branded and functional ingredients, and Carbyne Equity Partners today announced that SuanNutra has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The businesses will merge with SuanNutra's existing operations to create an enlarged global group in science-backed natural ingredients. The transaction is expected to complete by the end of 2026, subject to regulatory clearances and customary closing conditions.

Positioned to be a new category leader

The combination is a transformational step for SuanNutra, delivering directly on its strategy of scaling nutraceutical science into measurable impact and expanding into food-enhancement ingredients.

The incoming businesses bring an expanded range of clinically supported branded ingredients and owned botanical extraction at source, scientifically backed fermented vitamins and minerals, together with plant-derived natural colours, antioxidants and flavours.

The combined manufacturing footprint spans botanical extraction in Spain, Slovenia and Peru and fermentation in the United States. The merged group will have around 700 employees serving more than 1,200 customers in over 60 countries. Customers will continue to be served seamlessly, without interruption, and the group will continue to invest in commercial capability, R&D and innovation across the enlarged group.

The newly combined entity strengthens SuanNutra's Visible Health strategy – clinically backed ingredients delivering wellness benefits consumers can see and feel. In food enhancement, the natural colours, antioxidants and flavours place the group at the centre of the industry's shift from synthetic dyes, preservatives and flavours to natural and clean-label ingredients.

A winning matchup of complementary expertise

Anthony Weston, Group CEO of SuanNutra, said: "The engaged, experienced people in these businesses know the products and customers deeply, and that expertise is central to everything we aspire to achieve. Together we will build, grow and transform this group into a stronger partner for our customers offering manufacturing at source, clinically proven ingredients, and a broad natural portfolio across nutraceuticals and food enhancement."

Yoni Glickman, Non-Executive Chairman of SuanNutra, added: "Clinically supported branded ingredients are where this industry is heading – proven actives with the science to stand behind them. This expansion puts SuanNutra at the forefront of this transition. The move from artificial colours and preservatives to natural, scientifically substantiated ingredients is reshaping the food and health industries faster than ever."

Markus Petersen, Managing Partner of Carbyne Equity Partners, explained: "SuanNutra has a clear strategy and a management team that understands these businesses and their markets. This merger creates a botanical-based ingredients group of genuine scale and scientific credibility, and we are pleased to back the team in building it. We look forward to the opportunities these teams and SuanNutra will create together."

Mai Karas, Investment Director of Carbyne Equity Partners, concluded: "Specialty ingredients are at the heart of Carbyne's investment strategy. This transaction brings a global range of natural ingredients into the group and deepens our focus on the sector."

HSF Kramer acted as legal counsel to SuanNutra and Carbyne and EY acted as financial advisor.

View original content to download multimedia:https://www.prnewswire.com/news-releases/suannutra-a-carbyne-equity-partners-portfolio-company-expands-product-portfolio-with-specialty-natural-ingredients-businesses-from-iff-302829554.html

SOURCE SuanNutra

FAQ

What did SuanNutra announce about acquiring IFF (NYSE: IFF) specialty ingredients businesses?

SuanNutra announced an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). According to SuanNutra, these operations will merge with its existing activities to create a larger global group focused on science-backed natural and clean-label ingredients.

When is SuanNutra expected to complete the acquisition of IFF’s specialty ingredients businesses (IFF)?

The transaction is expected to complete by the end of 2026, subject to approvals. According to SuanNutra, closing depends on obtaining required regulatory clearances and satisfying customary closing conditions before integrating the acquired businesses into its global operations.

How will the IFF specialty ingredients acquisition change SuanNutra’s global scale and reach (IFF)?

After completion, the merged group will have around 700 employees and serve more than 1,200 customers. According to SuanNutra, operations will span over 60 countries, with manufacturing sites in Spain, Slovenia, Peru and the United States.

What types of products are included in the IFF specialty natural ingredients businesses acquired by SuanNutra (IFF)?

The acquired businesses add clinically supported branded ingredients and owned botanical extraction at source. According to SuanNutra, they also include scientifically backed fermented vitamins and minerals plus plant-derived natural colours, antioxidants and flavours for nutraceutical and food-enhancement applications.

How does the acquisition of IFF specialty ingredients support SuanNutra’s Visible Health strategy (IFF)?

The acquisition strengthens SuanNutra’s Visible Health strategy by expanding clinically backed ingredients with observable wellness benefits. According to SuanNutra, the enlarged portfolio supports the industry shift from synthetic dyes and preservatives to natural, clean-label, scientifically substantiated ingredients.

Who is backing SuanNutra’s acquisition of IFF’s specialty ingredients businesses and what is their focus (IFF)?

The transaction is backed by Carbyne Equity Partners, SuanNutra’s private equity owner. According to Carbyne, specialty ingredients are central to its investment strategy and this deal brings a broader global range of natural, botanical-based ingredients into the SuanNutra group.